Growing community of inventors

St-Laurent, Canada

Allan H Tse

Average Co-Inventor Count = 3.97

ph-index = 10

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 273

Allan H TseTarek S Mansour (10 patents)Allan H TseHaolun Jin (8 patents)Allan H TseColleen A Evans (5 patents)Allan H TseBoulos Zacharie (4 patents)Allan H TseNghe Nguyen-Ba (4 patents)Allan H TseM Arshad Siddiqui (4 patents)Allan H TseBernard R Belleau (2 patents)Allan H TseBernard Belleau, Deceased (2 patents)Allan H TseAllan H Tse (10 patents)Tarek S MansourTarek S Mansour (17 patents)Haolun JinHaolun Jin (12 patents)Colleen A EvansColleen A Evans (5 patents)Boulos ZacharieBoulos Zacharie (29 patents)Nghe Nguyen-BaNghe Nguyen-Ba (28 patents)M Arshad SiddiquiM Arshad Siddiqui (6 patents)Bernard R BelleauBernard R Belleau (16 patents)Bernard Belleau, DeceasedBernard Belleau, Deceased (8 patents)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Biochem Pharma Inc. (9 from 62 patents)

2. Shire Biochem, Inc. (1 from 16 patents)


10 patents:

1. 6831174 - Processes for preparing substituted 1, 3-oxathiolanes with antiviral properties

2. 6175008 - Processes for preparing substituted 1,3-oxathiolanes with antiviral properties

3. 5763606 - Stereoselective synthesis of nucleoside analogues using bicyclic

4. 5756706 - Processes for the diastereoselective synthesis of nucleoside analogues

5. 5744596 - Nucleoside analogues and synthetic intermediates

6. 5696254 - Processes for the diastereoselective synthesis of nucleoside analogues

7. 5693787 - Intermediates in the synthesis of 1,3-oxathiolanyl cytosine nucleoside

8. 5684164 - Processes for preparing substituted 1,3-oxathiolanes with antiviral

9. 5663320 - Processes for the diastereoselective separation of nucleoside analogue

10. 5466806 - Processes for preparing substituted 1,3-oxathiolanes with antiviral

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
1/3/2026
Loading…